Issue - meetings

Report of the Director of Public Health

Further to Minute No. 31 of the Health and Wellbeing Board of 6 March 2024, the Committee considered the report of the Director of Public Health which outlined the resources and processes required to deliver a fully revised three-year Sefton Pharmaceutical Needs Assessment (PNA) for 1 October 2025. The report provided information about:

• Legal context
• Uses of the PNA
• The range of information required
• Required and recommended steps and process
• Timescales
• Resource implications and collaboration

Members of the Committee asked questions/commented on the following issues:

·       Contributions by partners from outside the process and whether a similar process was undertaken with GPs.

·       Responsibility for delivery of covid vaccines.

RESOLVED: That

(1)      the large breadth and depth of information required by the yearlong PNA development process and final document, as set out in the ‘Pharmaceutical Needs Assessment Information Pack for Local Authority Health and Wellbeing Boards’ (DHSC, October 2021) be noted;

(2)      the opportunity cost in terms of public health analyst and consultant time be noted and proposals for organisations and partners with the most relevant knowledge and expertise to produce content for specified parts of the assessment, be endorsed.